StockData
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31

Agentix Corp.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$801.34K
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Agentix has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Agentix filed with the SEC